Bauernhofer, T; Schmid, M; Resel, M; Gilli, R; Halwachs, G; Lanzer, G; Wilders-Truschnig, M; Samonigg, H.
Detection of minimal residual disease in bone marrow (BM) peripheral blood (PB) and apheresis products (AP) in metastatic breast cancer patients receiving sequential dose intensive chemotherapy with PBPC support.
BONE MARROW TRANSPLANT 1999 23: S145-S145.
Web of Science